Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1.28M
-
Shares change
-
+168K
-
Total reported value, excl. options
-
$2.42M
-
Value change
-
+$315K
-
Put/Call ratio
-
0
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$1.89
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q4 2019
27 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q4 2019.
Altimmune, Inc. - Common Stock (ALT) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.28M shares
of 80.7M outstanding shares and own 1.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (534K shares), RENAISSANCE TECHNOLOGIES LLC (173K shares), WINTON GROUP Ltd (97.9K shares), GEODE CAPITAL MANAGEMENT, LLC (86.2K shares), Bank of New York Mellon Corp (76.3K shares), DIMENSIONAL FUND ADVISORS LP (53.9K shares), SABBY MANAGEMENT, LLC (44.9K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (36.1K shares), BlackRock Inc. (34.1K shares), and BANK OF AMERICA CORP /DE/ (25K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.